Building collaborations for cancer research and drug development
Capacity Development Core
This study is all about helping new cancer researchers at City of Hope and UC Riverside work together, get guidance from experienced mentors, and find funding to develop new cancer treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10933468 on NIH RePORTER |
What this research studies
This research focuses on enhancing collaboration between the City of Hope Comprehensive Cancer Center and the University of California, Riverside, particularly for early-stage investigators. It aims to provide mentorship and resources to help these investigators develop their capacity for drug development and secure independent NIH funding. The program includes funding for pilot projects that will be crafted by early-stage investigators under the guidance of experienced mentors. By fostering these partnerships, the initiative seeks to improve research outcomes and innovation in cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for participation are early-stage investigators in cancer research at the University of California, Riverside.
Not a fit: Patients who are not involved in cancer research or are not early-stage investigators may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved drug development processes and better funding opportunities for early-stage cancer researchers.
How similar studies have performed: Previous research has shown that mentorship and collaboration can significantly enhance the success rates of early-stage investigators in securing funding and advancing their projects.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Martinez, Ernest — University of California Riverside
- Study coordinator: Martinez, Ernest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.